Mirai Bio
Cambridge, Massachusetts, United States
Currently, genetic medicine delivery is limited to a small number of cell types with a narrow therapeutic window. Mirai’s platform is designed to understand the rules of delivery, enabling access to any tissue and any cell type. It has already unlocked previously inaccessible cell types with ML-derived lipids that outperform today’s commercial lipids.
Only accessible to MedStartr community members.
Join nowCompany Info
- Founded
- 2021
- Website
- www.miraibio.com/
Categories
Disease Areas
Technologies
Only accessible to MedStartr community members.
Join nowWhat do you think of Mirai Bio?
A HUGE part of what early stage companies, and even late stage ones, need and get on MedStartr is honest feedback from actual patients, clinicians, hospital leaders and industry insiders. It is very easy to get tunnel vision as a founder. Please tell the team that runs this company what you think.
Only accessible to MedStartr community members.
Join now